This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Glutamate receptor 3D structures
From Proteopedia
(Difference between revisions)
| Line 24: | Line 24: | ||
**[[5ybg]], [[5ybf]] - hIGluR2 LBD + potentiator + Glu<br /> | **[[5ybg]], [[5ybf]] - hIGluR2 LBD + potentiator + Glu<br /> | ||
**[[4u1y]], [[4u2p]], [[5l1b]] - rIGluR2 <br /> | **[[4u1y]], [[4u2p]], [[5l1b]] - rIGluR2 <br /> | ||
| + | **[[[6dlz]], [7rz9]] – rGluR2 – Cryo EM <br /> | ||
**[[5vov]], [[5vou]], [[5vot]] - rIGluR2 + calcium channel γ-2 – Cryo EM<br /> | **[[5vov]], [[5vou]], [[5vot]] - rIGluR2 + calcium channel γ-2 – Cryo EM<br /> | ||
**[[3n6v]], [[3o2j]], [[5n6p]] - rIGluR2 ATD (mutant) – rat<br /> | **[[3n6v]], [[3o2j]], [[5n6p]] - rIGluR2 ATD (mutant) – rat<br /> | ||
| Line 31: | Line 32: | ||
**[[3t93]], [[4u2r]] - rIGluR2 LBD (mutant)<br /> | **[[3t93]], [[4u2r]] - rIGluR2 LBD (mutant)<br /> | ||
**[[5fth]], [[5fti]], [[5ns9]] - rIGluR2 LBD (mutant) + Glu<br /> | **[[5fth]], [[5fti]], [[5ns9]] - rIGluR2 LBD (mutant) + Glu<br /> | ||
| + | **[[5kbs]], [[5kbt]], [[5kbu]] - rIGluR2 + antagonist – Cryo-EM<br /> | ||
**[[5kk2]], [[5vov]], [[5vou]], [[5vot]] - rIGluR2 + calcium channel γ2 subunit – Cryo-EM<br /> | **[[5kk2]], [[5vov]], [[5vou]], [[5vot]] - rIGluR2 + calcium channel γ2 subunit – Cryo-EM<br /> | ||
**[[6ucb]], [[6ud4]], [[6ud8]] - rIGluR2 + CNIH-3 + antagonist – Cryo-EM<br /> | **[[6ucb]], [[6ud4]], [[6ud8]] - rIGluR2 + CNIH-3 + antagonist – Cryo-EM<br /> | ||
| Line 55: | Line 57: | ||
**[[3h03]], [[3h06]], [[3b7d]], [[1n0t]], [[1ftl]], [[3tza]], [[3ua8]], [[4isu]], [[5cbs]], [[5cbr]], [[4yma]], [[6xsr]], [[6yk2]], [[6yk3]], [[6yk4]], [[6yk5]], [[6yk6]] - rIGluR2 LBD + antagonist<br /> | **[[3h03]], [[3h06]], [[3b7d]], [[1n0t]], [[1ftl]], [[3tza]], [[3ua8]], [[4isu]], [[5cbs]], [[5cbr]], [[4yma]], [[6xsr]], [[6yk2]], [[6yk3]], [[6yk4]], [[6yk5]], [[6yk6]] - rIGluR2 LBD + antagonist<br /> | ||
**[[1lb9]], [[4l17]], [[4u21]], [[4u22]], [[4u23]], [[5kbv]] - rIGluR2 LBD (mutant) + antagonist<br /> | **[[1lb9]], [[4l17]], [[4u21]], [[4u22]], [[4u23]], [[5kbv]] - rIGluR2 LBD (mutant) + antagonist<br /> | ||
| + | **[[5wek]], [[7rz4]], [[7rz5]] – rGluR2 + antagonist – Cryo EM <br /> | ||
*''GluR2 agonist complex'' | *''GluR2 agonist complex'' | ||
| Line 62: | Line 65: | ||
**[[1lbc]], [[5elv]] - rIGluR2 LBD (mutant) + agonist + Glu<br /> | **[[1lbc]], [[5elv]] - rIGluR2 LBD (mutant) + agonist + Glu<br /> | ||
**[[2p2a]], [[5buu]], [[6hch]], [[6hcc]], [[6hcb]] - rIGluR2 LBD + agonist + Glu<br /> | **[[2p2a]], [[5buu]], [[6hch]], [[6hcc]], [[6hcb]] - rIGluR2 LBD + agonist + Glu<br /> | ||
| + | **[[7ryy]], [[7ryz]], [[7rz7]], [[7rz8]], [[7rza]] – rGluR2 + agonist – Cryo EM <br /> | ||
*''GluR2 partial agonist complex'' | *''GluR2 partial agonist complex'' | ||
| Line 106: | Line 110: | ||
**[[5l2e]] – rIGluRδ2 extracellular domain<br /> | **[[5l2e]] – rIGluRδ2 extracellular domain<br /> | ||
**[[6lu9]] – rIGluRδ2 extracellular domain – Cryo EM<br /> | **[[6lu9]] – rIGluRδ2 extracellular domain – Cryo EM<br /> | ||
| + | **[[7z2r]] – rIGluRd2 LBD <br /> | ||
**[[5cc2]] – rIGluRδ2 LBD + agonist<br /> | **[[5cc2]] – rIGluRδ2 LBD + agonist<br /> | ||
| Line 111: | Line 116: | ||
**[[7occ]] – rIGluR1 + rGluR2 – Cryo EM <br /> | **[[7occ]] – rIGluR1 + rGluR2 – Cryo EM <br /> | ||
| - | **[[6qkz]], [[6qkc]], [[7ocd]] – rIGluR1 + rGluR2 + calcium channel γ-8 – Cryo EM <br /> | + | **[[6qkz]], [[6qkc]], [[7ocd]], [[7qhh]] – rIGluR1 + rGluR2 + calcium channel γ-8 – Cryo EM <br /> |
| - | **[[7oca]], [[7ocf]] – rIGluR1 + rGluR2 + calcium channel γ-8 + CNIH2 – Cryo EM <br /> | + | **[[7oca]], [[7oce]], [[7ocf]] – rIGluR1 + rGluR2 + calcium channel γ-8 + CNIH2 – Cryo EM <br /> |
| + | **[[5weo]], [[7tnk]], [[7tnl]], [[7tnm]], [[7tnn]], [[7tno]], [[7tnp]] – rIGluR1/calcium channel g-8 + drug – Cryo EM <br /> | ||
**[[6njl]] – rIGluR1 + rGluR2 + calcium channel γ-8 + SCFV + auxiliary protein + antibody – Cryo EM <br /> | **[[6njl]] – rIGluR1 + rGluR2 + calcium channel γ-8 + SCFV + auxiliary protein + antibody – Cryo EM <br /> | ||
| + | **[[7ryz]], [[7rz8]] – rGluR2 + agonist – Cryo EM <br /> | ||
| + | **[[7rz5]] – rGluR2 + antagonist – Cryo EM <br /> | ||
| + | **[[7qhb]], [[7rz6]] – rGluR2 + Glu – Cryo EM <br /> | ||
| + | **[[6dm1]], [[6o9g]] – rGluR2 + Glu + inhibitor – Cryo EM <br /> | ||
| + | **[[6dm0]] – rGluR2 + Glu + drug – Cryo EM <br /> | ||
| + | **[[7tnj]] – rGluR2 + drug – Cryo EM <br /> | ||
| + | **[[6zyu]] – rGluR2 LBD + Glu + inhibitor<br /> | ||
**[[6ovd]], [[6ove]] – rIGluR1 + rGluR2 residues 415-821 + antagonist<br /> | **[[6ovd]], [[6ove]] – rIGluR1 + rGluR2 residues 415-821 + antagonist<br /> | ||
**[[7ldd]], [[7lde]] – mIGluR1 + mGluR2 + calcium channel γ-8 + SCFV + antibody – Cryo EM <br /> | **[[7ldd]], [[7lde]] – mIGluR1 + mGluR2 + calcium channel γ-8 + SCFV + antibody – Cryo EM <br /> | ||
| Line 180: | Line 193: | ||
*Ionotropic kainate receptor 1 | *Ionotropic kainate receptor 1 | ||
| + | **[[7lvt]] – rGluK1 + Glu – Cryo EM<br /> | ||
**[[1ycj]] – rGluK1 LBD + Glu<br /> | **[[1ycj]] – rGluK1 LBD + Glu<br /> | ||
**[[5nf5]], [[5neb]] – rGluK1 LBD + Glu analog<br /> | **[[5nf5]], [[5neb]] – rGluK1 LBD + Glu analog<br /> | ||
| Line 188: | Line 202: | ||
*Ionotropic kainate receptor 2 | *Ionotropic kainate receptor 2 | ||
| + | **[[7f56]], [[7f57]], [[7f59]], [[7f5a]], [[7f5b]] - rGluK2 (mutant) + NETO2 – Cryo EM<br /> | ||
**[[3qxm]] - hGluK2 LBD + toxin<br /> | **[[3qxm]] - hGluK2 LBD + toxin<br /> | ||
**[[2xxr]] – rGluK2 LBD + Glu<br /> | **[[2xxr]] – rGluK2 LBD + Glu<br /> | ||
| Line 202: | Line 217: | ||
*Ionotropic kainate receptor 3 | *Ionotropic kainate receptor 3 | ||
| - | **[[6jfy]], [[6jfz]], [[6kzm]], [[6l6f]] - rGluK3 (mutant) – Cryo EM<br /> | + | **[[6jfy]], [[6jfz]], [[6kzm]], [[6l6f]], [[7vm2]] - rGluK3 (mutant) – Cryo EM<br /> |
**[[3olz]] – rGluK3 ATD<br /> | **[[3olz]] – rGluK3 ATD<br /> | ||
**[[6fjz]], [[6fjy]] - rGluK3 extracellular domain (mutant)<br /> | **[[6fjz]], [[6fjy]] - rGluK3 extracellular domain (mutant)<br /> | ||
| Line 227: | Line 242: | ||
**[[3qlu]] - rGluK5 + rGluK2 (mutant)<br /> | **[[3qlu]] - rGluK5 + rGluK2 (mutant)<br /> | ||
**[[3qlv]] - rGluK5 + rGluK2 | **[[3qlv]] - rGluK5 + rGluK2 | ||
| - | |||
| - | |||
*NMDA receptor (NMDAR) | *NMDA receptor (NMDAR) | ||
| Line 258: | Line 271: | ||
**[[7ujt]], [[7kl1]] - hNMDAR 1289-1310 (mutant) + CAMK2A + ATP<br /> | **[[7ujt]], [[7kl1]] - hNMDAR 1289-1310 (mutant) + CAMK2A + ATP<br /> | ||
**[[3jpy]], [[3jpw]] - rNMDAR ATD (mutant)<br /> | **[[3jpy]], [[3jpw]] - rNMDAR ATD (mutant)<br /> | ||
| - | **[[5up2]], [[5uow]] - XlNMDAR + NR2A + Fab + | + | **[[7ujr]] - rNMDAR 1289-1310 + CAMK2A <br /> |
| - | **[[5un1]] - XlNMDAR + methyl-aspartate receptor + | + | **[[5up2]], [[5uow]] - XlNMDAR + NR2A + Fab + Glu – Cryo-EM<br /> |
| + | **[[5un1]] - XlNMDAR + methyl-aspartate receptor + Glu <br /> | ||
*''NMDAR subunit NR3A'' | *''NMDAR subunit NR3A'' | ||
| Line 280: | Line 294: | ||
*''NMDAR subunit NR1+NR2A'' | *''NMDAR subunit NR1+NR2A'' | ||
| - | **[[7eos]] – hNMDAR (mutant) – Cryo EM<br /> | + | **[[7eos]], [[7eou]] – hNMDAR (mutant) – Cryo EM<br /> |
**[[5h8f]] – hNMDAR LBD <br /> | **[[5h8f]] – hNMDAR LBD <br /> | ||
**[[6mmx]], [[6mmw]], [[6mmv]], [[6mmu]], [[6mmt]], [[6mms]], [[6mmr]], [[6mmp]], [[6mmn]], [[6mmm]], [[6mml]], [[6mmk]], [[6mmj]], [[6mmi]], [[6mmh]], [[6mmg]], [[6mmb]], [[6mma]], [[6mm9]], [[6irh]], [[6irg]], [[6irf]], [[6ira]], [[6mm9]], [[6mma]], [[6mmb]], [[6mmg]], [[6mmh]], [[6mmi]], [[6mmj]], [[6mmk]], [[6mml]], [[6mmm]], [[6mmn]], [[6mmp]], [[6mmr]], [[6mms]], [[6mmt]], [[6mmu]], [[6mmv]], [[6mmw]], [[6mmx]] – rNMDAR – Cryo EM <br /> | **[[6mmx]], [[6mmw]], [[6mmv]], [[6mmu]], [[6mmt]], [[6mms]], [[6mmr]], [[6mmp]], [[6mmn]], [[6mmm]], [[6mml]], [[6mmk]], [[6mmj]], [[6mmi]], [[6mmh]], [[6mmg]], [[6mmb]], [[6mma]], [[6mm9]], [[6irh]], [[6irg]], [[6irf]], [[6ira]], [[6mm9]], [[6mma]], [[6mmb]], [[6mmg]], [[6mmh]], [[6mmi]], [[6mmj]], [[6mmk]], [[6mml]], [[6mmm]], [[6mmn]], [[6mmp]], [[6mmr]], [[6mms]], [[6mmt]], [[6mmu]], [[6mmv]], [[6mmw]], [[6mmx]] – rNMDAR – Cryo EM <br /> | ||
| Line 289: | Line 303: | ||
**[[5tpa]], [[5tp9]] – hNMDAR LBD + antagonist<br /> | **[[5tpa]], [[5tp9]] – hNMDAR LBD + antagonist<br /> | ||
| - | **[[7eoq]], [[7eot]] – hNMDAR (mutant) + antagonist – Cryo EM<br /> | + | **[[7eoq]], [[7eor]], [[7eot]] – hNMDAR (mutant) + antagonist – Cryo EM<br /> |
**[[5kdt]], [[5kcj]] – hNMDAR LBD + modulator<br /> | **[[5kdt]], [[5kcj]] – hNMDAR LBD + modulator<br /> | ||
**[[5tpa]], [[5tp9]], [[5kdt]], [[5kcj]], [[5i2n]], [[5i2k]], [[5h8q]], [[5h8n]], [[5h8h]] – hNMDAR LBD + allosteric modulator<br /> | **[[5tpa]], [[5tp9]], [[5kdt]], [[5kcj]], [[5i2n]], [[5i2k]], [[5h8q]], [[5h8n]], [[5h8h]] – hNMDAR LBD + allosteric modulator<br /> | ||
| Line 311: | Line 325: | ||
**[[5tpz]] – rNMDAR LBD <br /> | **[[5tpz]] – rNMDAR LBD <br /> | ||
**[[6wi0]] – rNMDAR + antagonist – Cryo EM <br /> | **[[6wi0]] – rNMDAR + antagonist – Cryo EM <br /> | ||
| + | **[[7te9]], [[7teb]], [[7tee]], [[7teq]], [[7tes]] – rNMDAR + antibody – Cryo EM <br /> | ||
| + | **[[7eu7]], [[7eu8]], [[7sac]] – rNMDAR + ketamine + Glu – Cryo EM <br /> | ||
| + | **[[7saa]] – rNMDAR + Glu – Cryo EM <br /> | ||
| + | **[[7sab]] – rNMDAR + PCP – Cryo EM <br /> | ||
| + | **[[7sad]] – rNMDAR + drug – Cryo EM <br /> | ||
**[[4pe5]], [[4tll]], [[4tlm]] – rNMDAR (mutants)<br /> | **[[4pe5]], [[4tll]], [[4tlm]] – rNMDAR (mutants)<br /> | ||
**[[5b3j]] – XlNMDAR1 ATD (mutant) + rNMDAR2B ATD (mutant) + antibody<br /> | **[[5b3j]] – XlNMDAR1 ATD (mutant) + rNMDAR2B ATD (mutant) + antibody<br /> | ||
| Line 317: | Line 336: | ||
**[[5ipu]], [[6e7x]], [[6e7w]], [[6e7v]], [[6e7u]], [[6e7t]], [[6e7s]], [[6e7r]] – XlNMDAR2B (mutant) + NMDAR1 (mutant) + inhibitor<br /> | **[[5ipu]], [[6e7x]], [[6e7w]], [[6e7v]], [[6e7u]], [[6e7t]], [[6e7s]], [[6e7r]] – XlNMDAR2B (mutant) + NMDAR1 (mutant) + inhibitor<br /> | ||
**[[3qel]], [[3qem]], [[5ewj]] – XlNMDAR ATD (mutant) + ifenprodil<br /> | **[[3qel]], [[3qem]], [[5ewj]] – XlNMDAR ATD (mutant) + ifenprodil<br /> | ||
| + | |||
| + | *''NMDAR subunit NR1+NR2C'' | ||
| + | |||
| + | **[[8e94]], [[8e97]] – hNMDAR – Cryo EM <br /> | ||
| + | **[[8e92]], [[8e93]], [[8e96]], [[8e98]] – hNMDAR + Glu + cyclo-Ser – Cryo EM <br /> | ||
| + | |||
| + | *''NMDAR subunit NR1+NR2A+NR2C'' | ||
| + | |||
| + | **[[8e99]] – hNMDAR + nanobody – Cryo EM <br /> | ||
*''NMDAR subunit NR1B+NR2B'' | *''NMDAR subunit NR1B+NR2B'' | ||
| Line 322: | Line 350: | ||
**[[6wi1]], [[6whr]], [[6whs]], [[6wht]], [[6whu]], [[6whv]] – rNMDAR – Cryo EM <br /> | **[[6wi1]], [[6whr]], [[6whs]], [[6wht]], [[6whu]], [[6whv]] – rNMDAR – Cryo EM <br /> | ||
**[[6whw]], [[6whx]], [[6why]] – rNMDAR + antagonist – Cryo EM <br /> | **[[6whw]], [[6whx]], [[6why]] – rNMDAR + antagonist – Cryo EM <br /> | ||
| + | **[[7ter]], [[7tet]] – rNMDAR + antibody – Cryo EM <br /> | ||
| + | **[[7te6]] – rNMDAR ATD + antibody <br /> | ||
| + | **[[8g18]] – rNMDAR ATD + inhibitor<br /> | ||
*NMDAR subunit NR1+NR2A+NR2B | *NMDAR subunit NR1+NR2A+NR2B | ||
Revision as of 08:50, 16 March 2023
3D structures of glutamate receptor
Updated on 16-March-2023
A topic page describing in detail the GluA2 structure described in 3kg2
